Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-004740
Filing Date
2025-04-15
Accepted
2025-04-15 13:42:41
Documents
69
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1659098
2 ex31-1.htm EX-31.1 11215
3 ex32-1.htm EX-32.1 7567
  Complete submission text file 0001641172-25-004740.txt   6468513

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sigy-20241231.xsd EX-101.SCH 44089
5 XBRL CALCULATION FILE sigy-20241231_cal.xml EX-101.CAL 53171
6 XBRL DEFINITION FILE sigy-20241231_def.xml EX-101.DEF 150490
7 XBRL LABEL FILE sigy-20241231_lab.xml EX-101.LAB 397794
8 XBRL PRESENTATION FILE sigy-20241231_pre.xml EX-101.PRE 310261
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 886188
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

EIN.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55575 | Film No.: 25838732
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)